{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/10/3309786/0/en/Nexalin-Technology-Reports-Compelling-Clinical-Trial-Results-in-Brazil-to-Support-Product-Launch-Trial-Demonstrates-77-8-Anxiety-Response-Rate-and-Durable-Benefits-Across-Depressio.html", "message": "News view counter 790827 successfully enlarged"}